Polyplus is formerly owned by ARCHIMED, through MED I, since 2016.

When did ARCHIMED acquire Polyplus?

ARCHIMED acquired Polyplus in 2016 and exited after 7 years.

Has Polyplus been sold?

Yes. Polyplus was exited in 2023 via Trade Sale.

Home/Companies/Biotech/Polyplus

Polyplus

Biotech·

France·Exited 2023·Held 7yr

Polyplus is a life science tools & biologic services company, headquartered in France.

Entry

2016

Hold

7yr

Exit

2023

Est. EV

–

Investor

ARCHIMED

Key facts

HQFrance

SectorLife Science Tools & Biologic Services

Headquartered in France, Polyplus-transfection (Polyplus) was founded in 2001 as a spin-off from the Genetic Chemistry Laboratory in the…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from MED I

Other portfolio companies in the same fund.

Esperion Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings